The activation or upregulation of DAPK1 in the brain has been reported to contribute to synaptic loss, Aβ generation and tau hyperphosphorylation in AD 12, 40, 41, while the molecular mechanism mediating DAPK1 upregulation in AD has not been revealed. This evidence concerns the gene MAPT and Alzheimer disease.